• Explore /
  • Poster
  • / RELAY+: Exploratory study of ramucirumab plus gefitinib in untreated patients (pts) with <em>epidermal growth factor receptor</em> (<em>EGFR</em>)-mutated metastatic non-small cell lung cancer (NSCLC).

RELAY+: Exploratory study of ramucirumab plus gefitinib in untreated patients (pts) with epidermal growth factor receptor (EGFR)-mutated metastatic non-small cell lung cancer (NSCLC).

Abstract Video & Slides Poster

Authors

null

Makoto Nishio

Thoracic Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan

Makoto Nishio , Kazuto Nishio , Martin Reck , Edward B. Garon , Fumio Imamura , Tomoya Kawaguchi , Hiroyuki Yamaguchi , Satoshi Ikeda , Katsuya Hirano , Carla M Visseren-Grul , Ryan C Widau , Annamaria H. Zimmermann , Gosuke Homma , Sotaro Enatsu , Kazuhiko Nakagawa

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Clinical Trial Registration Number

NCT02411448

Citation

J Clin Oncol 38: 2020 (suppl; abstr 9564)

DOI

10.1200/JCO.2020.38.15_suppl.9564

Abstract #

9564

Poster Bd #

330

Abstract Disclosures

Similar Posters

First Author: Min Hee Hong

First Author: Kazuto Nishio

First Author: Osvaldo Rudy Aren

First Author: Chuan Lu